WARF
Overview
WARF is the designated patenting and licensing organization for the University of Wisconsin-Madison, which supports scientific research within the UW-Madison community by providing financial support, actively managing assets, and moving innovations to the marketplace.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leo Cancer Care | Jun 2024 | Series C | Lead |
| Asto CT | May 2024 | Early Funding | Co-investor |
| Innervace | Sep 2022 | Series A | Co-investor |
| Elephas Biosciences | Sep 2022 | Series B | - |
Key People
Katie Rice
Principal - WARF Ventures
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is WARF based?
WARF is headquartered in Madison, Wisconsin, United States.
When was WARF founded?
WARF was founded in 1925.
How many portfolio companies does WARF have?
WARF has 4 portfolio companies in Caplight's dataset.
What are some companies in WARF's portfolio?
Recent investments visible on Caplight include Leo Cancer Care, Asto CT, Innervace, Elephas Biosciences, Asto CT.
What was WARF's most recent investment?
WARF's most recent investment on Caplight was in Leo Cancer Care in 2024.
What sectors does WARF focus on?
WARF focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does WARF focus on?
WARF typically invests at the Mid stage.